The scale of the study is what sets it apart. Between June 2021 and May 2025, the research team screened 1,093 patients admitted to stroke units at four Swedish hospitals: Umeå University Hospital, a tertiary care centre serving northern Sweden, along with Danderyd Hospital, Stockholm South General Hospital, and Kungälv Hospital. The cohort included 468 women, or 42.8 percent of participants, and had a median age of 75 years. By recruiting consecutive admissions rather than selected cases, the investigators minimised the selection bias that has plagued earlier studies, which often excluded the sickest patients—the very people most likely to have swallowing problems.

At the heart of the methodology lies the Gugging Swallowing Screen, known as GUSS, administered in its validated Swedish version by six trained research speech-language pathologists. Unlike simple water-swallow tests, GUSS is a step-wise instrument that evaluates vigilance, saliva management, voluntary cough, and the ability to swallow semi-solid, liquid, and solid boluses in a predefined hierarchical order. Total scores range from 0 to 20, with 20 indicating no dysphagia and progressively lower scores signalling mild, moderate, or severe impairment. The tool has demonstrated excellent sensitivity and specificity against instrumental gold standards such as videofluoroscopic swallowing studies and flexible endoscopic evaluation of swallowing—assessments that would have been impossible to deploy across a cohort of this size.

Even with such careful design, acute stroke medicine poses a practical dilemma: many patients in the first days after a stroke are too drowsy, aphasic, or cognitively impaired to cooperate with formal screening. To avoid excluding them, the researchers applied an ethically approved proxy method—a bedside water-swallowing assessment performed by stroke unit nurses using the Standardized Swallowing Assessment, which correlates strongly with GUSS. In total, 57 percent of patients were assessed directly with GUSS-S, while 43 percent entered the study through the proxy route. The mean time from admission to assessment was 37 hours, well within the 96-hour window that defines the acute phase.

Beyond establishing the headline incidence figure, the study identified which patients are most at risk. In multivariable regression models that adjusted for multiple factors simultaneously, five independent predictors of dysphagia emerged. Dysarthria—slurred or weakened speech resulting from damage to the motor speech network—carried an adjusted odds ratio of 1.85, meaning affected patients were nearly twice as likely to have swallowing impairment. This makes physiological sense: the muscles and neural circuits governing speech and swallowing overlap substantially, so impaired articulation can serve as a visible clinical flag for hidden swallowing dysfunction. Greater stroke severity, measured per point on the National Institutes of Health Stroke Scale, raised the odds by 16 percent with each increment, reflecting the wider disruption of cortical and subcortical swallowing networks as brain injury extends.

The remaining predictors were equally telling. Women faced 39 percent higher odds of dysphagia than men, a finding consistent with some prior research suggesting sex differences in stroke outcomes and swallowing physiology, though the authors note the literature remains mixed. Strokes located infratentorially—below the tentorium, in the brainstem and cerebellum—doubled the odds compared with supratentorial lesions, a result that aligns with decades of neuroanatomical evidence showing that the brainstem houses critical swallowing centres. Older age, modelled with a flexible cubic spline to capture its non-linear relationship with risk, was also independently associated with dysphagia, consistent with age-related decline in the strength and coordination of swallowing musculature. Notably, reperfusion therapies such as thrombolysis and thrombectomy, delivered to a substantial share of patients at the comprehensive stroke centre, were not independently linked to dysphagia once other factors were accounted for.

The consequences of dysphagia proved as consequential as its causes. Patients with swallowing impairment remained in hospital on average 1.64 times longer than those who could swallow normally—a difference that ripples through both individual recovery and healthcare economics. They were more than seven times as likely to require tube feeding, whether via nasogastric, nasoduodenal, nasojejunal, or surgically inserted gastrostomy tubes. Their odds of being discharged anywhere other than home were dramatically elevated: 4.84-fold for nursing homes, 4.69-fold for short-term care facilities, and roughly two to three times higher for transfers to other hospitals or wards. Most sobering of all, in-hospital death was associated with a 16.67-fold increase in odds among patients with dysphagia, even after adjustment for age, stroke severity, sex, and treatment centre.

Pneumonia, the most feared complication of swallowing impairment, told a similar story. When saliva, food, or liquid slips past the vocal folds into the trachea—a process called aspiration—bacteria can seed the lungs and ignite infection. In this cohort, pneumonia developed in 5.1 percent of all patients, but the burden fell unevenly: roughly one in ten patients with dysphagia developed pneumonia, compared with just 2 percent of those with normal swallowing, and dysphagia remained independently associated with the infection after adjustment. The overall pneumonia rate is lower than in many older studies, which the authors attribute partly to modern stroke care, including early mobilisation and routine dysphagia screening—practices that previous research has shown to reduce pneumonia rates when performed by trained staff.

Placed in historical context, the findings carry a subtle but important message. More than two decades ago, a landmark review by Martino and colleagues reported dysphagia rates of 37 to 45 percent when screening-based assessments were used, and 64 to 78 percent with instrumental methods. Despite revolutionary advances since then—acute reperfusion therapy, early mobilisation, coordinated multidisciplinary stroke unit care—the incidence observed in 2020s Sweden sits within that same screening-based range. This suggests that while stroke survival and acute management have improved enormously, the early burden of swallowing impairment has remained largely unchanged, likely because the underlying neuroanatomy of swallowing is highly individual and lesion-dependent, defying both generalisation and precise prediction of individual outcomes.

The authors are candid about their study’s limitations. Assessors could not be blinded to clinical information, since verifying eligibility required reviewing medical records that contained swallowing-related data, creating a potential for observer bias. Screening tools, however well validated, are less sensitive than instrumental videofluoroscopic or endoscopic examinations, so the true incidence may be somewhat higher. Some variables, including stroke severity scores, reperfusion data, and body-mass index, were missing for portions of the cohort, and tube feeding was identified solely through procedure codes, which may have led to underestimation. Yet sensitivity analyses using penalised regression produced consistent results, and the sheer scale, prospective design, and multicentre scope of the work make it one of the most robust estimates available. For clinicians, the takeaway is unambiguous: dysphagia affects more than a third of acute stroke patients, it announces itself through recognisable warning signs such as dysarthria and severe neurological deficits, and it demands early identification and targeted management to shorten hospital stays, prevent pneumonia, and keep patients on the path back home.

Subject of Research: Incidence and predictors of post-stroke dysphagia in acute stroke patients

Article Title: Incidence of dysphagia in acute stroke patients—a prospective multicentre cohort study

Article References: Selg, J., Mirkoska, V., Holmlund, T., Jäghagen, L., Wester, P., & Hägglund, P. (2026). Incidence of dysphagia in acute stroke patients—a prospective multicentre cohort study. Frontiers in Neurology, 17, Article 1886254. https://doi.org/10.3389/fneur.2026.1886254

Image Credits: AI Generated

DOI: 10.3389/fneur.2026.1886254

Keywords: stroke, dysphagia, swallowing disorders, aspiration, pneumonia, GUSS screening, speech-language pathology, stroke severity, NIHSS, dysarthria, brainstem stroke, cohort study

The research team, led by Chia-Ming Lin, Pei-Yun Li, Yu-Nan Huang, and Pen-Hua Su of Chung Shan Medical University Hospital in Taiwan, together with collaborators including Gideon Meyerowitz-Katz at the University of Wollongong in Australia, used the TriNetX US Collaborative Network, a massive repository of de-identified electronic health records spanning 2017 to 2025. Rather than running a prospective trial, which would take years and cost millions, they employed a technique known as target trial emulation. This approach borrows the design logic of a randomized controlled trial — defining eligibility criteria, treatment strategies, and follow-up windows as if a trial were being conducted — and then applies that blueprint to observational data, using statistical tools to approximate the balance that randomization would have achieved.

Specifically, the investigators emulated three separate active-comparator target trials in adults with type 2 diabetes undergoing thyroidectomy. Each trial compared preoperative continuation of a GLP-1 receptor agonist against a different alternative: dipeptidyl peptidase-4 inhibitors, sodium-glucose cotransporter-2 inhibitors, or usual care. To reduce the chance that sicker patients were systematically channeled into one drug class, the cohorts were 1:1 propensity score matched, a method that pairs patients across treatment groups based on their baseline characteristics. Cox proportional hazards models then estimated hazard ratios for each outcome, the standard statistical measure of how quickly events accumulate in one group relative to another over time.

The safety question at the heart of the study concerned aspiration, the feared complication in which stomach contents enter the airway during anesthesia. Because GLP-1 receptor agonists delay gastric emptying, anesthesiology societies have debated whether patients should hold these medications before surgery. In this analysis, however, aspiration-specific events fell below the minimum reportable cell size in every comparison and every postoperative window — meaning so few events occurred that reporting a hazard ratio would risk identifying individual patients. A broader postoperative respiratory composite outcome, which was prespecified precisely to capture this signal indirectly, showed no excess in the GLP-1 receptor agonist groups. For a surgical community hungry for reassurance, that absence of harm is itself a meaningful finding.

The thyroidectomy-specific complications told a similarly reassuring story. Recurrent laryngeal nerve injury, one of the most dreaded complications of thyroid surgery because it can permanently alter the voice, showed no excess in patients who continued GLP-1 receptor agonists. Hypocalcemia, a drop in blood calcium that follows disturbance of the parathyroid glands during thyroidectomy, was more frequent with GLP-1 receptor agonists than with SGLT2 inhibitors in the primary analysis, with a hazard ratio of 1.43 and a 95 percent confidence interval of 0.96 to 2.12 — a signal that grazed but did not cross the threshold of statistical significance. Notably, that signal did reach nominal significance in sensitivity analyses restricted to a two-year exposure window and to new users of the drugs, a pattern the authors treated with caution rather than as proof of a causal link.

The metabolic findings were more surprising. Patients who continued GLP-1 receptor agonists before surgery had a lower risk of diabetic ketoacidosis over 24 months compared with those on DPP-4 inhibitors, with a hazard ratio of 0.56 and a 95 percent confidence interval of 0.34 to 0.91. Diabetic ketoacidosis is a life-threatening emergency in which the body, starved of effective insulin action, produces dangerous levels of blood acids, and it has been a particular concern with SGLT2 inhibitors. The lower DKA risk was reproduced in both the exposure-window and new-user designs, lending it more internal consistency than many observational findings enjoy.

Mortality results generated the study’s most eye-catching numbers. GLP-1 receptor agonist continuation was associated with lower 24-month all-cause mortality compared with DPP-4 inhibitors, at a hazard ratio of 0.49 (95 percent confidence interval 0.26 to 0.92), and compared with SGLT2 inhibitors, at a hazard ratio of 0.39 (95 percent confidence interval 0.19 to 0.78). In plain terms, patients on GLP-1 drugs appeared roughly half as likely to die within two years as matched peers on the comparator drugs. Yet the authors themselves immediately tempered the excitement: the mortality findings were not reproduced in the exposure-window and new-user designs, mortality over the immediate postoperative periods of days 1 to 30 and 1 to 90 fell below the minimum reportable cell size in every comparison, and none of the significant results survived correction for multiple comparisons.

That last point deserves emphasis, because it captures the epistemological honesty that distinguishes careful pharmacoepidemiology from headline-chasing. When researchers test many outcomes across many comparisons, some associations will appear statistically significant by chance alone — the multiple-comparisons problem. Corrections such as false discovery rate control adjust for this inflation, and in this study every nominally significant finding dissolved under that scrutiny. The team also deployed negative-control outcomes, outcomes with no plausible biological connection to the drugs under study, and these were null, probing for residual confounding and finding no obvious trace of it. Still, the authors concluded that the lower DKA and mortality risks should be regarded as hypothesis-generating rather than as evidence for clinical action.

The practical takeaway for clinicians is nonetheless concrete. In adults with type 2 diabetes undergoing thyroidectomy, preoperative GLP-1 receptor agonist continuation was not associated with excess perioperative harm — no excess aspiration-related signal, no excess respiratory composite events, no excess recurrent laryngeal nerve injury. For surgeons and anesthesiologists who have faced the dilemma of whether to interrupt a patient’s diabetes therapy before an operation, the study offers the most procedure-specific evidence to date that continuation is compatible with perioperative safety. The findings align with a broader shift in perioperative medicine, where blanket drug-holding rules are increasingly replaced by procedure- and patient-specific risk assessments grounded in real-world data.

The study’s design also matters for how its results should be used. Because it emulated target trials in retrospectively collected, de-identified records, it was not a registered prospective clinical trial, and its matched cohorts — 722, 736, and 611 patients per arm across the three comparisons — were large but finite. Rare events like aspiration can escape detection even in cohorts of this size, and residual confounding can never be fully excluded in non-randomized data. The work was funded by Taiwan’s National Science and Technology Council and institutional grants from Chung Shan Medical University Hospital, with the funding sources having no role in the analysis or manuscript. The authors declare no competing interests. What the study delivers is a rigorously constructed, transparently reported foundation — one that flags no perioperative danger from continuing GLP-1 receptor agonists before thyroidectomy, and that sketches intriguing hypotheses about metabolic and survival benefits that only properly randomized trials can confirm.

Subject of Research: Perioperative safety of preoperative GLP-1 receptor agonist continuation in adults with type 2 diabetes undergoing thyroidectomy

Article Title: Preoperative GLP-1 receptor agonist continuation and perioperative safety after thyroidectomy in type 2 diabetes: a target trial emulation using a retrospective multicenter cohort

Article References: Lin, C.-M., Li, P.-Y., Chen, J.-C., Li, P.-H., Yang, H.-W., Meyerowitz-Katz, G., Huang, Y.-N., & Su, P.-H. (2026). Preoperative GLP-1 receptor agonist continuation and perioperative safety after thyroidectomy in type 2 diabetes: a target trial emulation using a retrospective multicenter cohort. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-026-02537-y

Image Credits: AI Generated

DOI: 10.1186/s12902-026-02537-y

Keywords: GLP-1 receptor agonist, thyroidectomy, type 2 diabetes, perioperative safety, aspiration, diabetic ketoacidosis, hypocalcemia, recurrent laryngeal nerve injury, target trial emulation, propensity score matching, pharmacoepidemiology, TriNetX

Accidental hydrocarbon ingestion is among the most frequent toxic exposures in young children worldwide, with the highest risk concentrated in those under six years of age. The reason is simple: hydrocarbons — the petroleum-derived liquids found in printer fluid, lamp oil, lighter fluid, furniture polish, and many household solvents — are colorful, often pleasantly scented, and stored in containers that small hands can easily open. What makes them particularly treacherous is not their toxicity when swallowed in the stomach, but what happens when even a tiny amount slips into the airways during the act of swallowing or vomiting.

The physics and chemistry of that injury are well understood. Low-viscosity hydrocarbons spread with almost no resistance across the delicate lining of the respiratory tract, rapidly coating the alveoli, the microscopic air sacs where oxygen exchange takes place. There they disrupt the surfactant layer that keeps the alveoli open, trigger an intense inflammatory reaction, and cause direct chemical injury to the lung tissue. The result is chemical pneumonitis — an inflammation of the lung that is not caused by infection but by the corrosive, solvent-like action of the hydrocarbon itself. Clinically, this can range from a mild cough to fulminant respiratory failure requiring mechanical ventilation.

In the Milan case, the toddler initially presented with mild respiratory symptoms and stable vital signs, a scenario that might easily have led to discharge after a short period of observation. Instead, his condition deteriorated. Imaging revealed progressive bilateral pulmonary consolidations, and within hours of admission the clinical team had to escalate care, admitting him to the Pediatric Intensive Care Unit and providing ventilatory support — first with continuous positive airway pressure, or CPAP, and subsequently with high-flow nasal cannula therapy, a technique that delivers warmed, humidified oxygen at high flow rates through nasal prongs. The rapid progression from a well-appearing child to one requiring intensive respiratory support illustrates the unpredictable trajectory that hydrocarbon aspiration can follow.

The complications did not stop there. During the hospital course, the child developed large bilateral pneumatoceles, thin-walled air-filled cavities that form when inflammation weakens the walls of the small airways, allowing air to become trapped within the lung parenchyma. Pneumatoceles are a rare but recognized delayed complication of hydrocarbon pneumonitis, and they can appear days after the initial exposure, sometimes in children whose early chest radiographs looked deceptively normal. In this case, the pneumatoceles gradually resolved on serial imaging, and the child made a complete clinical recovery, with follow-up at six and twelve months showing no residual sequelae.

The authors of the report, led by A. Bianchi and M. Ghezzi of the Pediatric Department at Buzzi Children’s Hospital, together with colleagues from the hospital’s Anesthesia and Critical Care Medicine unit and the University of Milan, paired the case with a review of the existing literature. Their central conclusion is a caution against premature reassurance: children who ingest hydrocarbons and show early respiratory symptoms or radiographic abnormalities may warrant prolonged observation, because deterioration can occur after an apparently benign first hour. The traditional practice of brief observation in the emergency department, they suggest, may not be sufficient for selected patients whose initial findings hint at aspiration.

The report also underscores a long-standing principle of hydrocarbon poisoning management: inducing vomiting is contraindicated. Because the lung injury is driven by aspiration rather than gastrointestinal absorption, forcing a child to vomit dramatically increases the risk that the liquid will be drawn into the airways. Gastric decontamination, which is a mainstay for many other poisonings, offers little benefit here and considerable harm. Instead, management is fundamentally supportive — oxygen, respiratory support ranging from CPAP to high-flow systems and, in the most severe cases, invasive mechanical ventilation — while the lungs heal themselves over days to weeks.

Diagnostic imaging plays a central role in tracking the injury. Chest radiographs are typically obtained early, but the Milan team’s experience shows why serial imaging matters: consolidations can progress over hours, and pneumatoceles may only become visible days later. The child in this case underwent chest computed tomography, which provided detailed visualization of the bilateral consolidations and the evolving cystic lesions. The gradual radiological resolution documented over the following months — paralleling the child’s full clinical recovery — highlights what pediatric pulmonologists have long observed: the developing lung has a remarkable capacity for regeneration, and even severe chemical pneumonitis can heal without lasting impairment when supportive care is adequate.

For parents and caregivers, the practical lessons are straightforward but vital. Hydrocarbon-containing products should be stored locked away and out of sight, ideally in their original containers with child-resistant caps intact. If ingestion does occur, caregivers should not induce vomiting; instead, they should contact emergency services or a poison control center immediately and bring the product container so that clinicians can identify the specific hydrocarbon involved. Because the viscosity of the ingested liquid is one of the strongest predictors of aspiration risk — with thin, watery liquids like printer fluid being far more dangerous than thick, syrupy ones — knowing exactly what the child swallowed can shape the entire clinical approach.

Beyond the individual case, the report carries a broader public health message. Household products containing low-viscosity hydrocarbons remain ubiquitous in homes with young children, and the gap between a child’s innocent curiosity and a life-threatening injury can be a single unscrewed cap. The Milan team’s experience — a mild presentation that escalated to intensive care, followed by delayed cystic lung damage and then a complete recovery — captures both the danger and the hope embedded in these poisonings. With vigilant observation, modern non-invasive respiratory support, and structured long-term follow-up, most children who aspirate hydrocarbons can be expected to recover fully. But the safest outcome, the authors emphasize, remains the one that never requires a trip to the pediatric intensive care unit at all, and that depends on prevention long before any emergency department becomes involved.

Subject of Research: Accidental hydrocarbon aspiration and chemical pneumonitis in a pediatric patient

Article Title: When curiosity turns toxic: accidental hydrocarbon aspiration in a pediatric patient – a case report with literature review

Article References: Bianchi, A., Ghezzi, M., Gambino, M., Bungaro, E., Farolfi, A., Morelli, M., Diotto, V., Izzo, F., Zoia, E., Zuccotti, G., D’Auria, E., & Ferrario, S. (2026). When curiosity turns toxic: accidental hydrocarbon aspiration in a pediatric patient – a case report with literature review. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07565-0

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07565-0

Keywords: hydrocarbon ingestion, chemical pneumonitis, pediatric poisoning, pneumatoceles, aspiration, pediatric intensive care, CPAP, high-flow nasal cannula, toxicology, printer fluid, child safety, BMC Pediatrics